BioQ Pharma
San Francisco, US · California corporation
BioQ Pharma is a pharmaceutical company with expertise in biotech development and healthcare technology. The company appears to be focused on pharmaceutical innovation with a board of directors drawn from senior executives with extensive experience in biotech, medical devices, and pharma commercialization.
Founders & leadership
JK
Josh KrieselCEO and Director
RP
Ron PauliinExecutive
Board
DT
Daniel TasseBoard director
NW
Norvall William Jasper, Jr.Board director
MJ
Mark J. EhlertBoard director
LK
Llew KeltnerBoard director
CP
Christopher PortmanBoard director
RN
Richard NesbitBoard director
Reported raises · per SEC filings
Form D private placements$76.1M disclosed across 5 rounds · 2014–2019
▶$4.6MraisedJan 2020 · 15 investors · PharmaceuticalsRule 506(b)
▶$4.6MraisedJan 2020 · 15 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joshua W. KrieselExecutive Officer, Director
- Ron PauliExecutive Officer
- Norvall William Jasper, Jr.Director
- Mark J. EhlertDirector
- Richard NesbitDirector
- Llew KeltnerDirector
- Christopher PortmanDirector
- Daniel TasseDirector
- Offering amount
- $18.8M
- Amount sold
- $4.6M
- First sale
- Dec 2019
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$36.4MraisedNov 2018 · 52 investors · PharmaceuticalsRule 506(b)
▶$36.4MraisedNov 2018 · 52 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ron PauliExecutive Officer
- Norvall William Jasper, Jr.Director
- Daniel TasseDirector
- Llew KeltnerDirector
- Christopher PortmanDirector
- Richard NesbitDirector
- Mark J. EhlertDirector
- Joshua W. KrieselExecutive Officer, Director
- Offering amount
- $45M
- Amount sold
- $36.4M
- Sales commissions
- $102K
- Placement agents
- Canaccord Genuity Inc.
- First sale
- Nov 2015
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$6.3MraisedAug 2017 · 2 investors · PharmaceuticalsRule 506(b)
▶$6.3MraisedAug 2017 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joshua W. KrieselExecutive Officer, Director
- Ron PauliExecutive Officer
- Daniel TasseDirector
- Richard NesbitDirector
- Norvall William Jasper, Jr.Director
- Mark J. EhlertDirector
- Christopher PortmanDirector
- Llew KeltnerDirector
- Offering amount
- $6.3M
- Amount sold
- $6.3M
- First sale
- Aug 2017
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$15MraisedOct 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$15MraisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ron PauliExecutive Officer
- Daniel TasseDirector
- Norvall William Jasper, Jr.Director
- Mark J. EhlertDirector
- Joshua W. KrieselExecutive Officer, Director
- Llew KeltnerDirector
- Christopher PortmanDirector
- Richard NesbitDirector
- Offering amount
- $15M
- Amount sold
- $15M
- Sales commissions
- $130K
- Placement agents
- Trump Securities, LLC
- First sale
- Oct 2016
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$13.7MraisedNov 2014 · 2 investors · Other Health CareRule 506(b)
▶$13.7MraisedNov 2014 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Christopher PortmanDirector
- Ron PauliExecutive Officer
- Llew KeltnerDirector
- Norvall William Jasper, Jr.Director
- Joshua W. KrieselExecutive Officer, Director
- Mark J. EhlertDirector
- Richard NesbitDirector
- Offering amount
- $13.7M
- Amount sold
- $13.7M
- Sales commissions
- $250K
- Placement agents
- Trump Securities, LLC
- First sale
- Oct 2014
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
STAQ Pharma13 shared keywordsSTAQ Pharma is an FDA-registered 503B outsourcing facility that compounds and supplies medications to hospitals and healthcare providers across the United States, aiming to address drug shortages. The company is owned and guided by several healthcare systems and focuses on safety, transparency, availability, and quality.
ResQ Pharma13 shared keywordsResQ Pharma is a pharmaceutical company developing LipidRescue (LRT), an investigational lipid-based drug therapy that is pending FDA approval. The company works on biologics development, regulatory affairs, and clinical research for its drug candidate.
IQVIA12 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Companies competing with BioQ Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does BioQ Pharma do?
- BioQ Pharma is a pharmaceutical company with expertise in biotech development and healthcare technology. The company appears to be focused on pharmaceutical innovation with a board of directors drawn from senior executives with extensive experience in biotech, medical devices, and pharma commercialization.
- Who founded BioQ Pharma?
- BioQ Pharma was founded by Josh Kriesel.
- How much funding has BioQ Pharma raised?
- BioQ Pharma has disclosed $76.1M raised across 5 rounds.
- Where is BioQ Pharma headquartered?
- BioQ Pharma is headquartered in San Francisco, US.